Proposed pathogenesis of painful bladder syndrome/interstitial cystitis

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 3 SUPPL., 2006, Pages 234-240

  Sand, Peter K ^a,b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c NONE   (United States)

Author keywords

Bladder diseases; Interstitial cystitis; Painful bladder syndrome; Pelvic pain

Indexed keywords

BIOLOGICAL MARKER; CYCLIC GMP; EPIDERMAL GROWTH FACTOR; ESTROGEN; GLYCOSAMINOGLYCAN; HEPARIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 6; PENTOSAN POLYSULFATE; POTASSIUM ION; SOMATOMEDIN BINDING PROTEIN 3; SUBSTANCE P; UREA;

AUTOIMMUNE DISEASE; BLADDER DISEASE; BLADDER EPITHELIUM; CELL ACTIVATION; CLINICAL FEATURE; ESTROGEN ACTIVITY; FEMALE; GENETIC PREDISPOSITION; HUMAN; INFECTION; INTERSTITIAL CYSTITIS; MAST CELL; MAST CELL DEGRANULATION; PATHOGENESIS; PELVIS FLOOR; PELVIS PAIN SYNDROME; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PSYCHOGENESIS; REVIEW; SENSORY NERVE; URINARY URGENCY; UROTHELIUM; BLADDER DYSFUNCTION; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; NEUROGENIC INFLAMMATION; PAINFUL BLADDER SYNDROME; PALLIATIVE THERAPY; PELVIC ORGAN PROLAPSE; PSYCHOLOGICAL ASPECT; RISK FACTOR;

CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; PELVIC PAIN; URINARY BLADDER DISEASES;

EID: 33645789251     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Burkman R: Chronic pelvic pain of bladder origin: Epidemiology, pathogenesis and quality of life. J Reprod Med 2004;49:225-229
2. Sant GR: Etiology, pathogenesis and diagnosis of interstitial cystitis. Rev Urol 2002;4:S9-S15
3. Parsons CL, Greenberger M, Gabal L, et al: The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998;159:1862-1866
4. Moldwin RM, Sant GR: Interstitial cystitis: A pathophysiology and treatment update. Clin Obstet Gynecol 2002;45:259-272
5. National Kidney and Urologic Diseases Information Clearinghouse: Interstitial Cystitis, http://kidney.niddk.nih. gov/kudiseases/pubs/ interstitialcystitis/index.htm, accessed January 24, 2006
6. Warren JW, Jackson TL, Langenberg P, et al: Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis. Urology 2004;63:17-21
7. Dimitrakov JD, Boyden SE, Freeman MR, et al: Single nucleotide polymorphism (SNP) analysis of autosomal dominant interstitial cystitis: A family-based study (abstr 303). Presented at American Urological Association Annual Meeting, San Antonio, May 21-26, 2005
8. Pang X, Marchand J, Sant GR, et al: Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 1995;75:744-750
9. Lukban JC, Parkin JV, Holzberg AS, et al: Interstitial cystitis and pelvic floor dysfunction: A comprehensive review. Pain Med 2001;2:60-71
10. Parsons CL: The therapeutic role of sulfated polysaccharides in the urinary bladder. Urol Clin North Am 1994;21:93-100
11. Parsons CL, Greene RA, Chung M, et al: Abnormal urinary potassium metabolism in patients with interstitial cystitis. J Urol 2005;173:1182-1185
12. Parsons CL: Evidence-based strategies for recognizing and managing IC. Comtemp Urol 2003;February:22-35
13. Dell JR, Parsons CL: Multimodal therapy for interstitial cystitis. J Reprod Med 2004;49:243-252
14. Chiang G, Patra P, Letourneau R, et al: Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: An alternative explanation of its beneficial effect in interstitial cystitis. J Urol 2000;164:2119-2125
15. Teichman JM: The role of pentosan polysulfate in treatment approaches for interstitial cystitis. Rev Urol 2002;4:S21-S27
16. Wesselmann U: Neurogenic inflammation and chronic pelvic pain. World J Urol 2001;19:180-185
17. Cervero F: Sensory innervation of the viscera: Peripheral basis of visceral pain. Physiol Rev 1994;74:95-138
18. Parsons CL: Current strategies for managing interstitial cystitis. Expert Opin Pharmacother 2004;5:287-293
19. Bouchelouche K, Kristensen B, Nordling J, et al: Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis. J Urol 2001;166:2121-2125
20. Sun Y, Chai TC: Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol 2004;171:448-452
21. Berkley KJ: A life of pelvic pain. Physiol Behav 2005;86:272-280
22. Lutgendorf SK, Kreder KJ: Central and peripheral mechanisms in interstitial symptoms. J Urol 2005;173:682
23. Theoharides TC, Cochrane DE: Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004;146:1-12
24. Metts JF: Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician 2001;64:1199-1206
25. Parsons C: Interstitial cystitis: epidemiology and clinical presentation. Clin Obstet Gynecol 2002;45:242-249
26. Peeker R, Atanasiu L, Logadottir Y: Intercurrent autoimmune conditions in classic and non-ulcer interstitial cystitis. Scand J Urol Nephrol 2003;37:60-63
27. Theoharides TC, Sant GR: The Mast Cell as a Neuroimmunoendocrine Effector in Interstitial Cystitis. In Interstitial Cystitis. Edited by GR Sant. Philadelphia, Lippincott-Raven, 1997, pp 101-108
28. Doggweiler-Wiygul R, Wiygul J: Interstitial cystitis, pelvic pain, and the relationship to myofascial pain and dysfunction: A report on four patients. World J Urol 2002;20:310-314
29. Oyama IA, Rejba A, Lukban JC, et al: Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology 2004;64:862-865
30. Tamaki M, Saito R, Ogawa O, et al: Possible mechanisms inducing glomerulations in interstitial cystitis: Relationship between endoscopic findings and expression of angiogenic growth factors. J Urol 2004;172:945-948
31. Keay S, Kleinberg M, Zhang CO, et al: Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J Urol 2000;164:2112-2118
32. Keay S, Zhang CO, Shoenfelt JL, et al: Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology 2003;61:1278-1284
33. Rashid HH, Reeder JE, O'Connell MJ, et al: Interstitial cystitis antiproliferative factor (APF) as a cell-cycle modulator. BMC Urol 2004;4:3
34. Keay S, Zhang CO, Chai T, et al: Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 2004;63:22-26
35. Zhang CO, Li ZL, Shoenfelt JL, et al: Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis. Urology 2003;61:897-901
36. Keay SK, Zhang CO, Shoenfelt J, et al: Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 2001;57:9-14
37. Erickson DR, Xie SX, Bhavanandan VP, et al: A comparison of multiple urine markers for interstitial cystitis. J Urol 2002;167:2461-2469
38. Slobodov G, Feloney M, Gran C, et al: Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 2004;171:1554-1558
39. Byrne DS, Sedor JF, Estojak J, et al: The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis. J Urol 1999;161:1786-1790
40. Weissman MM, Gross R, Fyer A, et al: Interstitial cystitis and panic disorder: A potential genetic syndrome. Arch Gen Psychiatry 2004;61:273-279
41. Theoharides TC: Panic disorder, interstitial cystitis, and mast cells. J Clin Psychopharmacol 2004;24:361-364
42. Marshall K: Interstitial cystitis: Understanding the syndrome. Altern Med Rev 2003;8:426-437
43. van de Merwe JP, Yamada T, Sakamoto Y: Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders. Int J Urol (suppl) 2003;10:S35-S38
44. Theoharides TC, Kempuraj D, Sant GR: Mast cell involvement in interstitial cystitis: A review of human and experimental evidence. Urology 2001;57:47-55
45. Bjorling DE, Wang ZY: Estrogen and neuroinflammation. Urology 2001;57:40-46
46. Domingue GJ, Ghoniem GM, Bost KL, et al: Dormant microbes in interstitial cystitis. J Urol 1995;153:1321-1326
47. Porru D, Polltano R, Gerardini M, et al: Different clinical presentation of interstitial cystitis syndrome. Int Urogynecol J Pelvic Floor Dysfunct 2004;15:198-202